Dose-finding for dobutamine during transitional circulation in the very preterm infant: The study protocol
PLOS One · 2025
DOI: 10.1371/journal.pone.0338307 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Maria Sanchez-Holgado und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, La Paz University Hospital, Hospital La Paz Institute for Health Research-IdIPAZ, Madrid, Spain. Hauptthemen laut MEDLINE: Dobutamine, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Hemodynamic insufficiency occurs when tissue oxygen delivery fails to meet demand. Preterm infants are vulnerable to early circulatory failure after birth, impacting mortality and morbidity. Mean arterial pressure is not a reliable indicator of systemic blood flow. Low superior vena cava (SVC) flow, independent of fetal shunts, has been proposed as a robust biomarker of circulatory impairment in this population. Dobutamine, a selective β1 agonist with minimal effect on systemic vascular resistances, is considered the treatment of choice for this condition. However, information about its optimal dosing, efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) profile in preterm infants is limited.
Methods
A multicenter, low-intervention, dose-finding trial will be conducted to establish the minimum effective dose of dobutamine to treat hemodynamic insufficiency, defined as SVC flow 55 mL/kg/min). The proportion of patients achieving and maintaining adequate hemodynamic status with dobutamine alone during the first 72 hours (efficacy), side effects, and variables explaining interindividual PK/PD variability will be explored.
Discussion
This study aims to define the minimum dose of dobutamine with a relevant PD effect on circulation in infants with hemodynamic insufficiency during transitional circulation. This is the first step towards future randomized clinical trials on efficacy and safety of dobutamine for the proposed indication.
Trial registration
EU Clinical trials register, EU CT 2023-504915-34-00, registered 18 April 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, La Paz University Hospital, Hospital La Paz Institute for Health Research-IdIPAZ, Madrid, Spain.
- Department of Pediatrics, Quirónsalud Madrid University Hospital, Hospital La Paz Institute for Health Research-IdIPAZ, Madrid, Spain.
- Neonatal Unit, Quirónsalud Madrid University Hospital, Madrid, Spain.
- Department of Neonatology, 12 de Octubre Hospital, Madrid, Spain.
- Clinical trials Unit, La Paz University Hospital, Madrid, Spain.
ORCID-Profile: Maria Sanchez-Holgado, Maria Carmen Bravo, Tania Carbayo Jimenez
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Sanchez-Holgado, M., Alvarez-Garcia, P., Bravo, M. C., Cabañas, F., López Azorin, M., Dorronsoro, I., Carbayo Jimenez, T., Maestro, M., Diago-Sempere, E., Seco-Meseguer, E., Jiménez-Gonzalez, M., & Pellicer, A. (2025). Dose-finding for dobutamine during transitional circulation in the very preterm infant: The study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0338307
Vancouver
Sanchez-Holgado M, Alvarez-Garcia P, Bravo MC, Cabañas F, López Azorin M, Dorronsoro I, et al. Dose-finding for dobutamine during transitional circulation in the very preterm infant: The study protocol. PLOS One. 2025. doi:10.1371/journal.pone.0338307
BibTeX
@article{SanchezHolgado2025,
author = {Sanchez-Holgado, Maria and Alvarez-Garcia, Patricia and Bravo, Maria Carmen and Cabañas, Fernando and López Azorin, Manuela and Dorronsoro, Izaskun and Carbayo Jimenez, Tania and Maestro, Maria and Diago-Sempere, Elena and Seco-Meseguer, Enrique and Jiménez-Gonzalez, María and Pellicer, Adelina},
title = {Dose-finding for dobutamine during transitional circulation in the very preterm infant: The study protocol},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0338307}
}
EUVIMED